NCT06279923View on ClinicalTrials.gov

CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Autoimmune Diseases
Interventions
BIOLOGICAL

CD19-BAFF Targeted CAR T-cells

Each subject receive CD19-BAFF Targeted CAR T-cells by intravenous infusion

Trial Locations (1)

310000

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER